Generic Manufacturers Face Uphill Climb After Federal Circuit’s ‘Skinny Label’ Decision

Skinny stamp
Appeals court declines to rehear 'skinny label' case on generic label carve-outs • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics